The ICPerMed believes personalised medicine could revolutionise healthcare by 2030. While the field does bring exciting progress, it also creates disparities, according to Yongjia Wang. Precision medicine, which uses genetic sequencing, is costly and the genomic research is unfairly balanced, with 80% coming from Europeans. Wang argues these issues, along with the question of who should cover treatment costs, creates an inequitable system where the rich benefit, while many others are left behind.
A division of United Healthcare, Change Healthcare, is dealing with the fallout of a cyber attack. This has heavily impacted the healthcare industry, affecting transactions